Welcome to the Academic Unit of Inflammation and Tumour Targeting

About Us

Our research focuses on:

• The role of macrophages in tumour progression, anti-cancer gene therapy and response of tumours to conventional therapies.
• Development of anti-vascular and angiogenic agents.
• Mathematical modelling of tumour inflammation and angiogenesis.

We gratefully acknowledge the financial support of:

• The Medical Research Council
• Cancer Research UK
• Yorkshire Cancer Research
• The Breast Cancer Campaign
• The Prostate Cancer Charity
• Various companies including AstraZeneca, MedImmune and Syntaxin.